+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Benlysta"

Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • July 2022
  • 225 Pages
  • Global
From
Systemic Lupus Erythematosus (SLE) Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Systemic Lupus Erythematosus (SLE) Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2025
  • 97 Pages
  • Global
From
Graves' Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Graves' Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • June 2023
  • 22 Pages
  • Global
Loading Indicator

Benlysta (belimumab) is a biologic drug used to treat systemic lupus erythematosus (SLE), an autoimmune disorder. It is the first and only FDA-approved treatment specifically for SLE. Benlysta works by blocking the activity of B-lymphocyte stimulator (BLyS), a protein that plays a role in the overactive immune response seen in SLE. It is administered as an intravenous infusion every four weeks. The Benlysta market is composed of a range of companies that produce and distribute the drug. These include pharmaceutical companies such as GlaxoSmithKline, Human Genome Sciences, and Merck, as well as biotechnology companies such as Humanigen and BioCryst Pharmaceuticals. Additionally, there are a number of generic drug manufacturers that produce generic versions of Benlysta. Show Less Read more